Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The potential change outlined in a statement would require all new vaccines to undergo “placebo” testing, sparking concerns ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

The FDA may be making changes to how it handles COVID-19 booster shots. The agency’s top official says they’re taking a closer look at whether to approve boosters for this winter.

This article is authored by Aditya Sharma, head, Process Solutions, India Region, Merck Life Science, New Delhi.

For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

The project is dedicated to safeguarding US vaccine use so that it remains grounded in the best available science, free from ...

After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it can ...

The (Santa Rosa) Press Democrat: Napa County’s $133 Million Jail To Open This Summer, With Shift Toward Rehabilitation, Mental Health Support Napa County’s long-anticipated new jail is slated ...